Cargando…

Editorial: Heterogeneity of clinical phenotypes in type 1 diabetes and of beta cell deterioration in type 1 diabetes

Detalles Bibliográficos
Autores principales:	Li, Xia, Zhang, Mei, Yan, Jinhua, Liu, Zhenqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853985/ https://www.ncbi.nlm.nih.gov/pubmed/36686459 http://dx.doi.org/10.3389/fendo.2022.1120555

Ejemplares similares

Editorial: Physical Activity and Type 1 Diabetes
por: Jendle, Johan H., et al.
Publicado: (2019)

Editorial: Revisiting cellular metabolism and type 1 diabetes
por: Chandra, Vikash, et al.
Publicado: (2023)

Editorial: Cell Transplantation in Diabetes: Cell-Based Immunotherapy for Type 1 Diabetes
por: Wei, Lingling, et al.
Publicado: (2022)

Defining the ferroptotic phenotype of beta cells in type 1 diabetes and its inhibition as a potential antidiabetic strategy
por: Markelic, Milica, et al.
Publicado: (2023)

Editorial: Footprints of Immune Cells in the Type 1 Diabetic Pancreas
por: Brusko, Todd M., et al.
Publicado: (2021)

Molecular Footprints of the Immune Assault on Pancreatic Beta Cells in Type 1 Diabetes
por: Colli, Maikel L., et al.
Publicado: (2020)

Editorial: Conditions and results of effective glycemic control in children with type 1 diabetes
por: Scaramuzza, Andrea Enzo, et al.
Publicado: (2022)

T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes
por: Burrack, Adam L., et al.
Publicado: (2017)

Editorial: Novel Biomarkers for Type 2 Diabetes
por: Ahluwalia, Tarunveer S., et al.
Publicado: (2019)

Editorial: The gut-pancreas axis in type 1 diabetes – a focus on environmental factors
por: Fløyel, Tina, et al.
Publicado: (2023)

Editorial: Daily challenges around physical exercise, nutrition and medication in type 1 diabetes
por: Moser, Othmar, et al.
Publicado: (2023)

The endocrine pancreas during exercise in people with and without type 1 diabetes: Beyond the beta-cell
por: McCarthy, Olivia, et al.
Publicado: (2022)

Gut microbiome and metabolic activity in type 1 diabetes: An analysis based on the presence of GADA
por: Luo, Sihui, et al.
Publicado: (2022)

HNF1A：From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus
por: Li, Li-Mei, et al.
Publicado: (2022)

Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
por: Luo, Jian-Quan, et al.
Publicado: (2023)

Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes
por: Nigi, Laura, et al.
Publicado: (2020)

Prediction and Prevention of Type 1 Diabetes
por: Primavera, Marina, et al.
Publicado: (2020)

Monitoring of Pediatric Type 1 Diabetes
por: Marks, Brynn E., et al.
Publicado: (2020)

Editorial: Optimizing Exercise for the Prevention and Treatment of Type 2 Diabetes
por: Karstoft, Kristian, et al.
Publicado: (2018)

Editorial: The link between obesity, type 2 diabetes, and mitochondria
por: Luo, Moulun, et al.
Publicado: (2023)

Targeting pancreatic beta cell death in type 2 diabetes by polyphenols
por: García-Aguilar, Ana, et al.
Publicado: (2022)

Evidence of Early Diabetic Nephropathy in Pediatric Type 1 Diabetes
por: Mamilly, Leena, et al.
Publicado: (2021)

Neuropsychological Outcomes in Individuals With Type 1 and Type 2 Diabetes
por: Putnam, Nathaniel M., et al.
Publicado: (2022)

Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement
por: Wan, Xin-Xing, et al.
Publicado: (2022)

Development of Type 1 Diabetes may occur through a Type 2 Diabetes mechanism
por: Josefsen, Knud, et al.
Publicado: (2022)

Neurodegeneration of the cornea and retina in patients with type 1 diabetes without clinical evidence of diabetic retinopathy
por: Carmichael, Josie, et al.
Publicado: (2022)

Editorial: The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
por: Blachnio-Zabielska, Agnieszka, et al.
Publicado: (2022)

Editorial: Non-insulin hypoglycemic drugs in type 2 diabetes remission
por: Guo, Kai-heng, et al.
Publicado: (2023)

Glycemic Variability and Diabetic Neuropathy in Young Adults With Type 1 Diabetes
por: Christensen, Marie Mathilde Bjerg, et al.
Publicado: (2020)

Research progress on the mechanism of beta-cell apoptosis in type 2 diabetes mellitus
por: You, SuFang, et al.
Publicado: (2022)

Environmental Factors Associated With Type 1 Diabetes
por: Esposito, Susanna, et al.
Publicado: (2019)

The Theory of Hyperlipidemic Memory of Type 1 Diabetes
por: Nwosu, Benjamin Udoka
Publicado: (2022)

Environmental Triggering of Type 1 Diabetes Autoimmunity
por: Houeiss, Pamela, et al.
Publicado: (2022)

Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes
por: Shi, Mei, et al.
Publicado: (2022)

Clinical Potential of Extracellular Vesicles in Type 2 Diabetes
por: Liu, Jie, et al.
Publicado: (2021)

Differential Expression of Human Peripheral Mononuclear Cells Phenotype Markers in Type 2 Diabetic Patients and Type 2 Diabetic Patients on Metformin
por: Al Dubayee, Mohammed S., et al.
Publicado: (2018)

Atrophy of the optic chiasm is associated with microvascular diabetic complications in type 1 diabetes
por: Tarkkonen, Aleksi, et al.
Publicado: (2023)

The Transgenerational Transmission of the Paternal Type 2 Diabetes-Induced Subfertility Phenotype
por: Zatecka, Eva, et al.
Publicado: (2021)

Association analysis between the TLR9 gene polymorphism rs352140 and type 1 diabetes
por: Wang, Yimeng, et al.
Publicado: (2023)

Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes
por: Liu, Xu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rp3v5dqf5daspnuvi7ats4g2u4